Characterization of discriminatory urinary proteomic biomarkers for severe preeclampsia using SELDI-TOF mass spectrometry

Journal of Perinatal Medicine

Volumn 39, Issue 4, 2011, Pages 391-396

  Lee, Seung Mi ^a   Park, Joong Shin ^a   Norwitz, Errol R ^b   Kim, Sun Min ^a   Kim, Byoung Jae ^a   Park, Chan Wook ^a   Jun, Jong Kwan ^a   Syn, Hee Chul ^a  

^a Seoul National University   (South Korea)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Preeclampsia; proteomics; scoring; surface enhanced laser desorption ionization (SELDI); urine

Indexed keywords

BETA LACTOGLOBULIN; BIOLOGICAL MARKER; MAGNESIUM SULFATE; MYOGLOBIN; SUPEROXIDE DISMUTASE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOWN REGULATION; FEMALE; HUMAN; MATERNAL AGE; MATERNAL HYPERTENSION; NULLIPARA; PREECLAMPSIA; PREECLAMPSIA PROTEOMIC SCORE OF URINE; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 79960255071     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2011.028     Document Type: Article

References (45)

1. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2002;99:159-67.
2. Aggarwal PK, Jain V, Sakhuja V, Karumanchi SA, Jha V. Low urinary placental growth factor is a marker of pre-eclampsia. Kidney Int. 2006;69:621-4. (Pubitemid 43164458)
3. Blankley RT, Gaskell SJ, Whetton AD, Dive C, Baker PN, Myers JE. A proof-of-principle gel-free proteomics strategy for the identification of predictive biomarkers for the onset of pre-eclampsia. Br J Obstet Gynaecol. 2009;116:1473-80.
4. Blumenstein M, McMaster MT, Black MA, Wu S, Prakash R, Cooney J, et al. A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease. Proteomics. 2009;9:2929-45.
5. Blumenstein M, Prakash R, Cooper GJ, North RA. Aberrant processing of plasma vitronectin and high-molecular-weight kininogen precedes the onset of preeclampsia. Reprod Sci. 2009;16:1144-52.
6. Buhimschi CS, Norwitz ER, Funai E, Richman S, Guller S, Lockwood CJ, et al. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am J Obstet Gynecol. 2005;192:734-41. (Pubitemid 40311263)
7. Buhimschi IA, Zhao G, Funai EF, Harris N, Sasson IE, Bernstein IM, et al. Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am J Obstet Gynecol. 2008;199:551 e1-16.
8. Carty DM, Delles C, Dominiczak AF. Novel biomarkers for predicting preeclampsia. Trends Cardiovasc Med. 2008;18: 186-94.
9. Cunningham FGLK, Bloom SL, Hauth JC, Gilstrap III L, Wenstrom KD. Implantation, embryogenesis, and placental development. In: Cunningham FG, editor. Williams Obstetrics. 22nd ed. New York: McGraw-Hill; 2005. p. 49.
10. Davidsson P, Westman-Brinkmalm A, Nilsson CL, Lindbjer M, Paulson L, Andreasen N, et al. Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients. Neuroreport. 2002;13:611-5. (Pubitemid 34293477)
11. Engwegen JY, Gast MC, Schellens JH, Beijnen JH. Clinical proteomics: searching for better tumour markers with SELDITOF mass spectrometry. Trends Pharmacol Sci. 2006;27: 251-9.
12. Ferrazzani S, Caruso A, De Carolis S, Martino IV, Mancuso S. Proteinuria and outcome of 444 pregnancies complicated by hypertension. Am J Obstet Gynecol. 1990;162:366-71. (Pubitemid 20068498)
13. Gamez-Pozo A, Sanchez-Navarro I, Nistal M, Calvo E, Madero R, Diaz E, et al. MALDI profiling of human lung cancer subtypes. PLoS One. 2009;4:e7731.
14. Garovic VD, Wagner SJ, Turner ST, Rosenthal DW, Watson WJ, Brost BC, et al. Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol. 2007;196:320 e1-7.
15. Grill S, Rusterholz C, Zanetti-Dallenbach R, Tercanli S, Holzgreve W, Hahn S, et al. Potential markers of preeclampsia - a review. Reprod Biol Endocrinol. 2009;7:70.
16. Hamar BD, Buhimschi IA, Sfakianaki AK, Pettker CM, Magloire LK, Funai EF, et al. Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe preeclampsia. Am J Obstet Gynecol. 2006;195:1636-45. (Pubitemid 44792629)
17. Higgins JR, de Swiet M. Blood-pressure measurement and classification in pregnancy. Lancet. 2001;357:131-5. (Pubitemid 32094921)
18. Huang YJ, Xuan C, Zhang BB, Liao M, Deng KF, He M, et al. SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2009;28:85.
19. Kanmura S, Uto H, Kusumoto K, Ishida Y, Hasuike S, Nagata K, et al. Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system. Hepatology. 2007;45:948-56. (Pubitemid 46631563)
20. Khalil A, Jauniaux E, Harrington K, Muttukrishna S. Placental production and maternal serum and urine levels of inhibin A and activin A are modified by antihypertensive therapy in hypertensive disorders of pregnancy. Clin Endocrinol (Oxf). 2009;70:924-31.
21. Kharb S. Serum markers in pre-eclampsia. Biomarkers. 2009; 14:395-400.
22. Kronborg CS, Allen J, Vittinghus E, Knudsen UB. Pre-symptomatic increase in urine-orosomucoid excretion in preeclamptic women. Acta Obstet Gynecol Scand. 2007;86: 930-7. (Pubitemid 47123610)
23. Leanos-Miranda A, Marquez-Acosta J, Cardenas-Mondragon GM, Chinolla-Arellano ZL, Rivera-Leanos R, Bermejo-Huerta S, et al. Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes. J Clin Endocrinol Metab. 2008;93: 2492-9. (Pubitemid 352008512)
24. Lee J, Park JS, Norwitz ER, Kim BJ, Park CW, Jun JK, et al. Identification and characterization of proteins in amniotic fluid that are differentially expressed before and after antenatal corticosteroid administration. Am J Obstet Gynecol. 2010;202:388 e1-10.
25. Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, et al. Urinary placental growth factor and risk of preeclampsia. J Am Med Assoc. 2005;293:77-85. (Pubitemid 40066702)
26. Li L, Tang H, Wu Z, Gong J, Gruidl M, Zou J, et al. Data mining techniques for cancer detection using serum proteomic profiling. Artif Intell Med. 2004;32:71-83. (Pubitemid 39201347)
27. Myers J, Macleod M, Reed B, Harris N, Mires G, Baker P. Use of proteomic patterns as a novel screening tool in preeclampsia. J Obstet Gynaecol. 2004;24:873-4. (Pubitemid 41001755)
28. Navaglia F, Fogar P, Basso D, Greco E, Padoan A, Tonidandel L, et al. Pancreatic cancer biomarkers discovery by surfaceenhanced laser desorption and ionization time-of-flight mass spectrometry. Clin Chem Lab Med. 2009;47:713-23.
29. Norwitz ER, Tsen LC, Park JS, Fitzpatrick PA, Dorfman DM, Saade GR, et al. Discriminatory proteomic biomarker analysis identifies free hemoglobin in the cerebrospinal fluid of women with severe preeclampsia. Am J Obstet Gynecol. 2005; 193:957-64. (Pubitemid 41285477)
30. Park JS, Oh KJ, Norwitz ER, Han JS, Choi HJ, Seong HS, et al. Identification of proteomic biomarkers of preeclampsia in amniotic fluid using SELDI-TOF mass spectrometry. Reprod Sci. 2008;15:457-68. (Pubitemid 351832780)
31. Paweletz CP, Trock B, Pennanen M, Tsangaris T, Magnant C, Liotta LA, et al. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Markers. 2001;17: 301-7. (Pubitemid 34014685)
32. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002;359:572-7. (Pubitemid 34178440)
33. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22.
34. Roes EM, Raijmakers MT, Roelofs HM, Peters WH, Steegers EA. Urinary GSTP1-1 excretion is markedly increased in normotensive pregnancy as well as in preeclampsia. J Nephrol. 2005;18:405-8. (Pubitemid 41700103)
35. Roes EM, Steegers EA, Thomas CM, Geurts-Moespot A, Raijmakers MT, Peters WH, et al. High levels of urinary vascular endothelial growth factor in women with severe preeclampsia. Int J Biol Markers. 2004;19:72-5. (Pubitemid 38515015)
36. Savvidou MD, Akolekar R, Zaragoza E, Poon LC, Nicolaides KH. First trimester urinary placental growth factor and development of pre-eclampsia. Br J Obstet Gynaecol. 2009;116: 643-7.
37. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785-99. (Pubitemid 40311367)
38. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102:181-92. (Pubitemid 36792143)
39. Thangaratinam S, Coomarasamy A, OMahony F, Sharp S, Zamora J, Khan KS, et al. Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review. BMC Med. 2009;7:10.
40. Vascotto C, Salzano AM, DAmbrosio C, Fruscalzo A, Marchesoni D, di Loreto C, et al. Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia. J Proteome Res. 2007;6:160-70. (Pubitemid 46173668)
41. Ward DG, Suggett N, Cheng Y, Wei W, Johnson H, Billingham LJ, et al. Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer. 2006;94:1898-905. (Pubitemid 43882582)
42. Watanabe H, Hamada H, Yamada N, Sohda S, Yamakawa- Kobayashi K, Yoshikawa H, et al. Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia. Proteomics. 2004;4:537-43. (Pubitemid 38235273)
43. Weinberger SR, Morris TS, Pawlak M. Recent trends in protein biochip technology. Pharmacogenomics. 2000;1:395-416.
44. Wiemer JC, Prokudin A. Bioinformatics in proteomics: application, terminology, and pitfalls. Pathol Res Pract. 2004;200: 173-8. (Pubitemid 38950447)
45. Wilkins MR, Sanchez JC, Gooley AA, Appel RD, Humphery- Smith I, Hochstrasser DF, et al. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev. 1996;13:19-50.